Charles Schwab’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-60,952	Closed	-$138K	–	3633
2024 Q1	$138K	Sell	60,952 -11,791	-16%	-$28.3K	﹤0.01%	3278
2023 Q4	$213K	Hold	72,743	–	–	﹤0.01%	3271
2023 Q3	$308K	Hold	72,743	–	–	﹤0.01%	3207
2023 Q2	$638K	Buy	+72,743	New	+$396K	﹤0.01%	2938
2023 Q1	–	Sell	-3,395	Closed	-$41.4K	–	3557
2022 Q4	$41.4K	Hold	3,395	–	–	﹤0.01%	3398
2022 Q3	$29K	Hold	3,395	–	–	﹤0.01%	3439
2022 Q2	$56K	Sell	3,395 -22,389	-87%	-$256K	﹤0.01%	3379
2022 Q1	$311K	Hold	25,784	–	–	﹤0.01%	3209
2021 Q4	$421K	Buy	25,784 +1,507	+6%	+$30.3K	﹤0.01%	3200
2021 Q3	$386K	Buy	24,277 +2,758	+13%	+$132K	﹤0.01%	3213
2021 Q2	$1.99M	Buy	21,519 +18,701	+664%	+$1.19M	﹤0.01%	2715
2021 Q1	$147K	Hold	2,818	–	–	﹤0.01%	3352
2020 Q4	$77K	Buy	2,818 +2,268	+412%	+$57.5K	﹤0.01%	3333
2020 Q3	$16K	Hold	550	–	–	﹤0.01%	3323
2020 Q2	$8K	Hold	550	–	–	﹤0.01%	3316
2020 Q1	$7K	Hold	550	–	–	﹤0.01%	3222
2019 Q4	$12K	Hold	550	–	–	﹤0.01%	3169
2019 Q3	$13K	Hold	550	–	–	﹤0.01%	3168
2019 Q2	$17K	Sell	550 -1,868	-77%	-$55.9K	﹤0.01%	3206
2019 Q1	$50K	Buy	+2,418	New	+$41.8K	﹤0.01%	3126